when will retatrutide be released eli lilly release date Eli Lilly's retatrutide is still in clinical trials. But gym bros This weight-loss drug hasn't been
Description
Adv Rheumatol
Guyton J et al
Earlier this month, researchers at Harvard University published the results of their recent study, which observed an increased risk of nonarteritic anterior ischemic optic neuropathy (NAION) in patients taking semaglutide for type 2 diabetes or weight loss
Priority review status, which would likely apply to Retatrutide given the obesity epidemic, can reduce approval time to 180 days versus the standard 300 days
has served as a consultant or speaker within the past 12 months to Altimmune, Amgen, Arrowhead, AstraZeneca, Boehringer Ingelheim, Kallyope, Merck Research Laboratories, Novo Nordisk Inc., Pfizer Inc and Zealand Pharma
